Approval · Notice of Compliance 15315 · 2014
PENTASA SUPPOSITORIES: Notice of Compliance 15315
Issued February 24, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15315
- Date
- February 24, 2014
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing process
- Therapeutic class
- Gastroinestinal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTASA SUPPOSITORIES | Not yet assigned | — |
Medicinal ingredients
- MESALAZINE 1 G per UNIT